Friday, August 15th, 2025

Suntar Eco-City Limited 1H 2025 Financial Results: Revenue Down, Higher Profits, No Interim Dividend Declared

Suntar Eco-City Limited: 1H 2025 Financial Results Analysis

Suntar Eco-City Limited, a Singapore-listed company, has released its condensed interim financial statements for the six months ended 30 June 2025. The Group operates in two main segments: Health and Nutrition, and Property Development. This article reviews key financial metrics, performance trends, and material events from the report to provide a comprehensive update for investors.

Key Financial Metrics

Metric 1H 2025 2H 2024 1H 2024 YoY Change QoQ Change
Revenue (RMB’000) 1,287 (not disclosed) 5,894 -78.2% n/a
Gross Profit (RMB’000) 388 (not disclosed) 320 +21.3% n/a
Net Profit (RMB’000) 2,024 (not disclosed) 932 +117.2% n/a
EPS (cents, Basic/Diluted) 3.15 (not disclosed) 1.47 +114.1% n/a
Dividend per Share (cents) 0.00 0.00 0.00 No change No change
Gross Profit Margin (%) 30.2 (not disclosed) 5.4 +2,073 bps n/a

Historical Performance and Trends

  • Revenue: The Group’s revenue declined sharply by 78.2% YoY, falling from RMB 5.89 million in 1H 2024 to RMB 1.29 million in 1H 2025. This decrease is attributed to lower sales in the Health and Nutrition segment, particularly in health supplements, due to industry slowdown, changing market demands, and heightened competition.
  • Gross Profit Margin: Despite the revenue drop, the gross profit margin improved significantly to 30.17% from 5.43% a year ago, driven by the discontinuation of low-margin raw material trading and a focus on higher-margin premium products and corporate clients.
  • Net Profit & EPS: Net profit more than doubled YoY, reaching RMB 2.02 million (EPS: 3.15 cents) versus RMB 0.93 million (EPS: 1.47 cents) in 1H 2024. This improvement is largely due to a substantial increase in share of profits from associates, especially from property development projects.
  • Operating Cash Flow: The Group had a net cash outflow from operating activities of RMB 8.06 million, mostly due to settlement of payables and reduced trade receivables. Cash and cash equivalents fell drastically from RMB 57.79 million at FY2024 year-end to RMB 10.83 million, reflecting significant investments in structured deposits and payments related to property transactions.
  • Dividends: No interim dividend was declared for the period, consistent with prior practice of declaring dividends only on a full-year basis.

Segmental Review

  • Health and Nutrition: All Group revenue originated from this segment. Bottled water sales were RMB 1.06 million and health supplements RMB 0.23 million. The revenue decline in supplements was not fully offset by new product launches, as market headwinds persist.
  • Property Development: No direct revenue was recognized from this segment, but the share of profit from associates (notably Wuping Hailan Real Estate Development Co., Ltd.) increased, contributing RMB 2.75 million, reflecting handover progress at the Lanjun Jiangnan project.

Balance Sheet and Cash Flow Highlights

  • Structured Deposits: RMB 44.03 million was invested in structured deposits as at 30 June 2025, compared to none at year-end 2024. This represents a significant redeployment of cash resources and may impact liquidity until maturity.
  • Receivables and Payables: Trade receivables and payables both decreased, reflecting reduced sales activity and settlement of a major property-related payable.
  • Loan Position: All borrowings are unsecured and short-term (RMB 21.2 million, up from RMB 19.8 million at year-end), with no long-term debt outstanding.

Material Events and Other Disclosures

  • Related-party Transactions: A major cash outflow (RMB 6.69 million) was related to the settlement of a property transaction with a related party.
  • Legal/Regulatory: Higher administrative expenses were due in part to legal costs from a property transaction recession, but no ongoing litigation or material disputes were disclosed.
  • Divestments, IPOs, Fundraising: No such events occurred during the period.
  • Share Capital: No change in share capital; no buybacks, dilution, or new mandates reported.
  • Subsequent Events: No subsequent events requiring adjustment were disclosed.

Management Commentary and Outlook

“In the Health and Nutrition segment, revenue from health supplements declined, due to challenges faced by traditional distribution channels amid evolving market conditions. The Group continues to optimize its product portfolio, focusing on vitamins, protein powders, and tea products. Efforts are also underway to expand distribution channels for the bottled water brand and to explore new market opportunities beyond current regions. The Group will continue to monitor market developments closely and adjust strategies accordingly to support sustainable performance.

In the Property Development segment, sales of the Jiangnan project progressed steadily despite the challenging conditions in the Chinese real estate market. As we continue to make progress on the Lanjun Jiangnan project, we see it as an opportunity to strengthen our brand presence in the market. By delivering quality residential units and villas, we aim to build a reputation for excellence. Moving forward, we are focused on completing the remaining phases of the Jiangnan project and expect it to serve as a foundation for further growth in our property development portfolio.”

The management’s tone is cautiously optimistic for property, but acknowledges persistent challenges in Health and Nutrition.

Conclusion and Investment Recommendations

Overall Assessment: Suntar Eco-City’s 1H 2025 results show a dramatic revenue decline, but profitability has improved due to higher gross margins and strong profit contributions from associates. Liquidity has tightened with significant cash tied up in structured deposits, and ongoing headwinds in the Health and Nutrition sector remain a concern. The property segment offers some promise through associate contributions, but visibility on direct topline growth remains low.

  • If you are currently holding this stock:

    Consider maintaining your position if you are comfortable with the Group’s focus on margin expansion and the potential for property associate contributions to drive future profits. However, monitor liquidity closely and be aware of the risks in the health supplement market and the Group’s reliance on investment income.
  • If you are not currently holding this stock:

    Potential investors may wish to remain on the sidelines until there is clearer evidence of a sustainable turnaround in revenue growth, particularly in the Health and Nutrition segment, and improved direct cash flows. The lack of dividends and shrinking cash reserves may also be a deterrent for income-focused investors.

Disclaimer: This analysis is for informational purposes only and is based solely on the company’s disclosed interim financial statements. It does not constitute investment advice. Investors should conduct their own research and consider their own risk tolerance before making any investment decisions.

View Suntar Eco-City Historical chart here



Protelindo Q3 2024 Financial Report: Net Profit Stable at IDR 2.49 Trillion Amid Asset and Revenue Growth

Financial Analysis of PT Profesional Telekomunikasi Indonesia (Protelindo) – Report as of September 30, 2024 Business Overview Core Operations: PT Profesional Telekomunikasi Indonesia, along with its subsidiaries, operates in telecommunication infrastructure, focusing on the...

Quantum Healthcare Limited: Independent Auditor’s Report and Financial Statements for FY2024

Net Profit Decline: Quantum Healthcare Limited’s Financial Report Analysis Company Overview Quantum Healthcare Limited is a Singapore-registered company primarily engaged in the healthcare business, specifically in the provision of dental services. The company has...

Kencana Agri Limited 1H 2025 Performance Review: Strong Revenue and Profit Growth, Operational Highlights & Financial Summary (No Dividend Details Available)

Kencana Agri Limited 1H 2025 Financial Results: Strong Rebound Drives Profitability Kencana Agri Limited, a palm oil producer with operations across Sumatra, Kalimantan, and Sulawesi, has delivered an impressive set of results for the...